期刊文献+

妊娠相关性再生障碍性贫血13例 被引量:2

下载PDF
导出
摘要 目的了解妊娠相关性再生障碍性贫血的临床特征和母婴结局,探讨治疗方法。方法回顾性分析本院近10年13例妊娠相关性再生障碍性贫血的临床资料。结果有贫血症状11例(84.62%),出血症状6例(46.15%),发热4例(30.77%)。4例孕早期中,仅1例完成妊娠,1例自然流产,2例选择人工流产;其余10例完成妊娠者中,分娩孕周30~36周,其中经阴道自然分娩4例,剖宫产6例,均为活产。产妇除1例产后并发严重产褥感染死亡外,其余均存活。妊娠相关性再生障碍性贫血预后:基本治愈9例,余3例达缓解标准。无新生儿死亡病例。结论妊娠相关性再障在育龄期再障患者中比例不低,妊娠在一定程度上可成为再障发生的诱因,妊娠中晚期发病者经积极药物及输血治疗母婴妊娠结局良好。
出处 《浙江实用医学》 2013年第4期271-273,共3页 Zhejiang Practical Medicine
基金 浙江省中医药重大疾病科技创新平台科研专项2009ZDJB01 2011年浙江省科技厅创新团队(No.2011R09042-02)
  • 相关文献

参考文献10

  • 1Young N S, Scheinberg P, Calado R T. Aplastic anemia. Curr Opin Hematol, 2008,15 : 162.
  • 2侯文杰,王子莲,陈海天,詹雁峰,李铭岚,胡明晶.妊娠相关性再生障碍性贫血9例临床分析[J].新医学,2009,40(9):603-605. 被引量:1
  • 3Kulagink A D, Lisukov I A, Kriuchkova I V, et al. Diagnosis and treat- ment of aquired aplastic anemia. Terarldi, 2006,78 ( 11 ) : 48.
  • 4曹泽毅.中华妇产科学.2版.北京:人民卫生出版社,2005:844-845.
  • 5王汝芹,张文艺,胡小梅.妊娠合并再生障碍性贫血的临床及试验研究[J].中国保健,2006(4):45-46. 被引量:1
  • 6Brabin B J, Hakimi M. Pelletier D. An analysis of anemia and preg- nancy- related maternal mortality. J Nutr,2001,131 (2S- 2):604.
  • 7康格非.临床生物化学[M].北京:人民出版社,1995.277.
  • 8Deka D, Malhotra N, Sinha A, et al. Pregnancy associated aplastic anemia maternal and fetal outcome. Jobstet Gynaecol Res, 2003,29 (2) : 67.
  • 9Thakral B, Salu JAK, Sharma R R. Successful management of pregnan- cy - associated severe aplastic anemia. Eur JO bstet Gynecol Repred Biol, 2007,131 (2) :244.
  • 10Song M K, Chung J S, Joo Y D, et al. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? Eur J Haemato,2009,83(1) :72.

二级参考文献18

  • 1王山米,杨京晶.妊娠合并再生障碍性贫血的诊治[J].中国实用妇科与产科杂志,2004,20(5):270-272. 被引量:12
  • 2黄科,黄绍良,方建培,钟凤仪,周敦华,李栋方,岑丹阳.强化免疫抑制治疗儿童再生障碍性贫血疗效分析[J].中山大学学报(医学科学版),2004,25(5):486-488. 被引量:7
  • 3DEKA D, MALHOTRA N, SINHA A, et al. Pregnancy associated aplastic anemia: maternal and fetal outcome [J]. J Obstet Gynaecol Res, 2003, 29 (2): 67-72.
  • 4KULAGIN A D, LISUKOV I A, KRIUCHKOVA I V, et al. Diagnosis and treatment of aquired aplastie anemia [J]. 俄文, 2006, 78 (11): 48-54.
  • 5KAO S Y, XU W, BRANDWEIN J M, et al. Outcomes of older patients ( > or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy [J] . Br J Haematol, 2008, 143 (5) : 738-743.
  • 6GURION R, GAFTER-GVILI A, PAUL M, et al. Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis[ J]. Haematologiea, 2009, 94 (5) : 712-719.
  • 7KWON J Y, LEE Y, SHIN J C, et al. Supportive management of pregnancy-associated aplastic anemia [J]. Int J Gynaecol Obstet, 2006, 95 (2) : 115-120.
  • 8SONG M K, CHUNG J S, JOO Y D, et al. Is the early eyelosporine A level predictive of the outcome of immu- nosuppressive therapy in severe aplastic anemia? [ J ] Eur J Haematol, 2009, 83 ( 1 ) : 72-78.
  • 9THAKRAL B, SALUJA K, SHARMA R R. Successful management of pregnancy-associated severe aplastic ane- mia[J]. Eur J Obstet Gynecol Reprod Biol, 2007, 131 (2) : 244-245.
  • 10[1]张之南,主编.血液病诊断及疗效标准.天津:天津科技出版社,1990.

共引文献41

同被引文献22

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部